Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Therapeutics

Aged Patients Should Benefit from Neuronal Stem Cell Therapy

Neurodegenerative researchers have demonstrated the potential of stem cell therapy for treating elderly individuals with age-related neurological illnesses. More...
28 Jun 2016

Stem Cell Therapy Shows Promise as Treatment for Pituitary Gland Failure

The potential use of diverse hormone-releasing pituitary cells derived from human pluripotent stem cells (hPSCs) to treat hypopituitarism was demonstrated in a rat model. More...
28 Jun 2016

Genomics Assay Provides Companion Diagnostic for Some Intellectual Disabilities

A new study is one of the first to show the benefits of whole exome sequencing (WESeq) based diagnostics for children with certain kinds of intellectual disability, enabling physicians to prescribe more appropriate, personalized treatment. More...
07 Jun 2016

Researchers Generate Stem Cell-derived Beta-cells from Patients with Diabetes

Diabetes researchers have succeeded in generating functional insulin-secreting beta cells from stem cells derived from patients with the type I form of the disease. More...
01 Jun 2016

Novel Gene Therapy Approach Kills Glioblastoma Tumors In Vitro and In Vivo

Gene therapy to increase expression of the enzyme Emx2 (Homeobox protein Emx2) in glioblastoma multiforme (GBM) tumor cells was shown to destroy the cancer in vitro and prevent its recurrence in vivo. More...
31 May 2016

Novel Gene Therapy Approach Kills Glioblastoma Tumors in Vitro and in VivoNovel Gene Therapy Approach Kills Glioblastoma Tumors in Vitro and in Vivo

Gene therapy to increase expression of the enzyme Emx2 (Homeobox protein Emx2) in glioblastoma multiforme (GBM) tumor cells was shown to destroy the cancer in vitro and prevent its recurrence in vivo. More...
27 May 2016

Study Improves Understanding of E. coli H30 Epidemiology, Persistent Infections Remains Unexplained

Researchers have identified populations more vulnerable to infection with pandemic E. coli strain H30, however improved testing is needed to monitor patients due to the high rate of treatment failure. Antibiotic resistance and weakened immunity only partially explain persistent infection. More...
05 May 2016


BioResearch Therapeutics channel deals with all aspects of therapies beyond the five-year horizon.
Copyright © 2000-2016 Globetech Media. All rights reserved.